ada.enesco, Author at European Medical Journal - Page 53 of 65

Semaglutide Reduces Hidradenitis Suppurativa Symptoms: EADV 2024

New research presented at EADV 2024 highlights semaglutide’s potential in reducing flare-ups and improving quality of life for hidradenitis suppurativa patients.

Testing Uncovers Hidden Germline Variants in Genitourinary Cancers

Research highlights the significance of universal germline genetic testing in uncovering pathogenic germline variants across various genitourinary malignancies.

Plant-Based Diet Linked to Slower Prostate Cancer Progression

A recent cohort study has shed light on the potential benefits of plant-based diets for men diagnosed with prostate cancer

Lifestyle Changes Help Counteract Diabetes-Induced Brain Ageing

Diabetes has long been recognised as a risk factor for dementia, but new research reveals its connection to accelerated brain ageing

Night-Time Light Exposure Linked to Higher Type 2 Diabetes Risk

Circadian rhythm disruption has been strongly linked to the development of Type 2 diabetes.

Does COVID-19 Reduce Male Fertility?

A meta-analysis reveals that COVID-19 significantly affects male fertility, reducing sperm concentration, motility, and altering reproductive hormones.

Early Peanut Consumption Reduces Allergy Risk In Adolescence

Recent research underscores the long-lasting benefits of early peanut introduction in preventing peanut allergy.

Viagra Reduces the Incidence of Emergency Caesarean Section

Recent research investigates the effectiveness of sildenafil citrate in reducing fetal distress and emergency caesarean section during labour.

Paediatric Allergic Rhinitis Symptoms Eased with Immunotherapy

A new study shows that allergy immunotherapy may offer relief for young children with allergic rhinitis while also reducing asthma risks.

FLOW Trial Shows Benefit of Semaglutide in Type 2 Diabetes and CKD: EASD 2024

Findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes and chronic kidney disease, were presented at EASD 2024.